Growth Metrics

Incyte (INCY) Net Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 49,253.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 506.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -569.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 7,218.00
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn 2,115.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2,115.00
Dec 31, 2025 1,679.00
Sep 30, 2025 1,735.00
Jun 30, 2025 1,561.00
Mar 31, 2025 984.00
Dec 31, 2024 -4,828.00
Sep 30, 2024 -1,300.00
Jun 30, 2024 -6,377.00
Mar 31, 2024 1,039.00
Dec 31, 2023 86.00
Sep 30, 2023 2,109.00
Jun 30, 2023 -2,087.00
Mar 31, 2023 12,944.00
Dec 31, 2022 -1,609.00
Sep 30, 2022 -956.00
Jun 30, 2022 -216.00
Mar 31, 2022 -1,537.00
Dec 31, 2021 5,228.00
Sep 30, 2021 1,587.00
Jun 30, 2021 1,113.00
Mar 31, 2021 1,961.00
Dec 31, 2020 5,267.00
Sep 30, 2020 -1,190.00
Jun 30, 2020 4,602.00
Mar 31, 2020 -7,805.00
Dec 31, 2019 1,644.00
Sep 30, 2019 957.00
Jun 30, 2019 590.00
Mar 31, 2019 1,142.00
Dec 31, 2018 -955.00
Sep 30, 2018 2,759.00
Jun 30, 2018 434.00
Mar 31, 2018 76.00
Dec 31, 2017 -389.00
Sep 30, 2017 -2,047.00
Jun 30, 2017 3,320.00
Mar 31, 2017 -1,089.00
Dec 31, 2016 4,688.00
Sep 30, 2016 3,957.00
Jun 30, 2016 1,651.00
Mar 31, 2016 3,117.00
Dec 31, 2015 613.00
Sep 30, 2015 1,479.00
Jun 30, 2015 104.00
Mar 31, 2015 11,403.00
Dec 31, 2014 16,086.00
Sep 30, 2014 34,620.00
Jun 30, 2014 27,152.00
Mar 31, 2014 4,510.00
Dec 31, 2013 -8,206.00
Sep 30, 2013 16,200.00
Jun 30, 2013 -864.00
Mar 31, 2013 18,462.00